Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Codivir in Outpatients With COVID-19
NCT04930861Phase 1Completed
- Sponsor
- Code Pharma
- Start
- Mar 2021
- Primary completion
- May 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Codivir in coronavirus disease 2019 (COVID-19), sponsored by Code Pharma. Primary endpoint: Incidence and severity of adverse events related to the investigational product at 28 days. Started Mar 2021; status: completed.
02
Drugs
Codivir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04930861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04930861.